Rosuvastatin Reduces Plaque Volume in STEMI PatientsRosuvastatin Reduces Plaque Volume in STEMI Patients

Rosuvastatin 40 mg reduced plaque burden in the non-infarct-related arteries of STEMI patients undergoing PCI. It did not, however, alter the phenotype of the lesion. Heartwire
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news